HCC
AGN

Hirtle Callaghan & Co’s Allergan plc AGN Stock Holding History

Hirtle Callaghan & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20
Closed -$3K – 80
2019
Q1 		$3K Buy
+20
New +$2.9K ﹤0.01% 65
2018
Q2 		– Sell
-20
Closed -$3K – 137
2018
Q1 		$3K Hold
20
– – ﹤0.01% 122
2017
Q4 		$3K Sell
20
-96
-83% -$17.2K ﹤0.01% 137
2017
Q3 		$24K Hold
116
– – ﹤0.01% 144
2017
Q2 		$28K Sell
116
-28
-19% -$6.58K ﹤0.01% 106
2017
Q1 		$34K Hold
144
– – 0.01% 110
2016
Q4 		$30K Sell
144
-3,296
-96% -$683K 0.01% 92
2016
Q3 		$792K Hold
3,440
– – 0.16% 36
2016
Q2 		$795K Sell
3,440
-766
-18% -$177K 0.15% 37
2016
Q1 		$1.13M Buy
4,206
+2,685
+177% +$769K 0.21% 27
2015
Q4 		$477K Buy
1,521
+49
+3% +$14.6K 0.11% 13
2015
Q3 		$402K Hold
1,472
– – 0.07% 31
2015
Q2 		$447K Buy
+1,472
New +$439K 0.15% 25

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hirtle Callaghan & Co's AGN Position: Q2 2019 in Review

Hirtle Callaghan & Co sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 20 shares — an estimated $3K sold.

Hirtle Callaghan & Co first reported a position in AGN in Q2 2015 and held it in 13 quarters. The position peaked at $1.13M in Q1 2016. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Hirtle Callaghan & Co reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 20 Allergan plc shares in Q2 2019, an estimated $3K.
  • Hirtle Callaghan & Co first reported a position in Allergan plc in Q2 2015 and held it in 13 quarters.
  • Hirtle Callaghan & Co's Allergan plc position peaked at $1.13M in Q1 2016.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q2 2019, filed 13 Aug 2019.